AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliminyle-MV1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Erinyle Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Gliminyle-MV1 Tablet SR

Gliminyle-MV1 SR tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. They help regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms (sweating, dizziness, headache, tremors) and manage them promptly. Maintain regular meals and carry readily available glucose sources. Alcohol consumption should be limited due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Gliminyle-MV1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Gliminyle-MV1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gliminyle-MV1 Tablet SR on an empty stomach.

Common Side effects of Gliminyle-MV1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Gliminyle-MV1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Gliminyle-MV1 Tablet SR on an empty stomach.

How Gliminyle-MV1 Tablet SR works:

Gliminyle-MV1 Extended-Release Tablets contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliminyle-MV1 Tablet SR with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gliminyle-MV1 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Gliminyle-MV1 tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Gliminyle-MV1 Tablet SR carries a high risk of adverse effects in individuals with kidney impairment and its use should be strictly avoided. Medical advice is essential. Furthermore, this medication is contraindicated for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Gliminyle-MV1 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, Gliminyle-MV1 Tablet SR is contraindicated in those with severe liver disease.

What if you forget to take Gliminyle-MV1 Tablet SR :

Should you forget to take a Gliminyle-MV1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Gliminyle-MV1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliminyle-MV1 Tablet SR

Gliminyle-MV1 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple-action therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Gliminyle-MV1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, taste changes, gas, stomach pain, headache, rash, and respiratory infections.
Gliminyle-MV1 Tablet SR is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Gliminyle-MV1 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Gliminyle-MV1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Gliminyle-MV1 Tablet SR
148
MRP 180
17% off